Effect of a Dose-Escalation Regimen for Improving Adherence to Roflumilast in Patients with Chronic Obstructive Pulmonary Disease
Hyunjung Hwang, Ji Young Shin, Kyu Ree Park, Jae Ouk Shin, Kyoung-hwan Song, Joonhyung Park, Jeong Woong Park
Tuberc Respir Dis. 2015;78(4):321-325.   Published online 2015 Oct 1     DOI: https://doi.org/10.4046/trd.2015.78.4.321
Citations to this article as recorded by Crossref logo
The Dosing Strategy to Improve Adherence to Roflumilast in Treatment for Chronic Obstructive Lung Disease: A Systemic Review and Meta-Analysis
Jonghoo Lee, Jae-Uk Song
International Journal of Chronic Obstructive Pulmonary Disease.2024; Volume 19: 655.     CrossRef
Revue générale sur l’adhésion aux traitements inhalés de la BPCO
F. Dalon, E. Van Ganse, C. Correia Da Silva, G. Nachbaur, L. Saïl, M. Belhassen
Revue des Maladies Respiratoires.2019; 36(7): 801.     CrossRef
Management of COPD in Asia: A position statement of the Asian Pacific Society of Respirology
Chin Kook Rhee, Ngo Quy Chau, Faisal Yunus, Kazuto Matsunaga, Diahn‐Warng Perng
Respirology.2019; 24(10): 1018.     CrossRef
Incidence of Adverse Effects and Discontinuation Rate between Patients Receiving 250 Micrograms and 500 Micrograms of Roflumilast: A Comparative Study
Hyonsoo Joo, Deokjae Han, Jae Ha Lee, Chin Kook Rhee
Tuberculosis and Respiratory Diseases.2018; 81(4): 299.     CrossRef
Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease
Dave Singh, Nicolas Roche, David Halpin, Alvar Agusti, Jadwiga A. Wedzicha, Fernando J. Martinez
American Journal of Respiratory and Critical Care Medicine.2016; 194(5): 541.     CrossRef
The discovery of roflumilast for the treatment of chronic obstructive pulmonary disease
Mario Cazzola, Luigino Calzetta, Paola Rogliani, Maria Gabriella Matera
Expert Opinion on Drug Discovery.2016; 11(7): 733.     CrossRef
Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis
Paola Rogliani, Luigino Calzetta, Mario Cazzola, Maria Gabriella Matera
Expert Opinion on Drug Safety.2016; 15(8): 1133.     CrossRef